David OFFEN,Roy RABINOWITZ,Tall BEN-ZUR,Daniel MICHAELSON
申请号：
US16498993
公开号：
US20200046853A1
申请日:
2018.03.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to improvement and therapy of neuronal conditions involving neurodegenerative, inflammatory and vascular conditions. More specifically, the invention provides compositions and methods for specific targeted elimination of apolipoprotein E4 (apoE4), and uses thereof in the treatment and prevention of ApoE4 associated conditions.
